Skip to main content
Caplight Logo









CrisprBits

CrisprBits

Private
DelhiHealthcare & Life Scienceshttps://crisprbits.com/

Last Round

Series A

Nov 25, 2025

Est. Valuation

$12M

Total Funding Raised

$3.25M

Company Overview

CrisprBits is a biotechnology company that develops diagnostic tests and gene-editing technology platforms for healthcare, food safety, and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Revenue Share, Hardware Sales

AI Layer

Infrastructure

Keywords

CRISPR diagnosticsgene editingmolecular diagnosticspoint-of-need diagnosticspoint-of-care testingrapid diagnostic testsPOCTstrain engineeringsynthetic biologysynbioindustrial biotechnologyantimicrobial resistance testingsickle cell disease diagnosticsfood safety testinganimal health diagnosticsbiofuel productionrare disease therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CrisprBits Comparables

Compare CrisprBits with similar companies based on industry and business-model similarity.

CrisprBits comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VedaBio
81%
Seek Labs
79%
Scope Biosciences
77%

CrisprBits Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 25, 2025
Pre SeedFeb 13, 2023

CrisprBits Investors

Notable investors and investment history

CrisprBits investors
InvestorRounds
Spectrum ImpactSeries A
Centre for Cellular and Molecular PlatformsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2025

    Grew 27% QoQ, from 22 to 28 employees.

  • Jul 21, 2025

    Grew 30% QoQ, from 20 to 26 employees.

CrisprBits Filings

Explore SEC and related filing metadata, where available.

CrisprBits filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CrisprBits's valuation, stock price, and market status.

Is CrisprBits a public or private company?

CrisprBits is a private company.

What is the current stock price of CrisprBits?

CrisprBits is a private company with no public stock price. No recent secondary market data is available.

How much is CrisprBits worth (valuation)?

Valuation information for CrisprBits is not publicly available.

Can I buy CrisprBits stock?

CrisprBits shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CrisprBits's last funding round?

Funding round information for CrisprBits is not publicly available.

Who are the main investors in CrisprBits?

Investor information for CrisprBits is not publicly disclosed.

Will CrisprBits IPO soon?

No public IPO plans have been announced for CrisprBits.

How can I track CrisprBits secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CrisprBits's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDelhi
Employee Range28
Year Founded2020
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?